Endothelial dysfunction is characterized by impaired endothelium-dependent dilation (EDD) secondary to reduced bioactivity of the vasodilator molecule nitric oxide (NO) [3], and increased vascular tone mediated by the potent vasoconstrictor peptide endothelin-1 (ET-1) [4–6]. This evidence concerns the gene EDN1 and endothelial dysfunction.